Michael Fraser
Impact in
- Cancer Research top 5%
- Oncology top 5%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
Papers in
-
- Cell death mechanisms and regulation 8
- Molecular Biology Techniques and Applications 4
- Cancer-related gene regulation 3
-
- Prostate Cancer Treatment and Research 16
- Prostate Cancer Diagnosis and Treatment 9
- Co-authors
- Benjamin K. Tsang (11 shared papers)Robert G. Bristow (22 shared papers)Xiaojuan Yan (3 shared papers)Theodorus van der Kwast (16 shared papers)Xiaokui Yang (2 shared papers)Brendan M. Leung (2 shared papers)Tao Bai (1 shared paper)Han C. Dan (2 shared papers)
- Journals
- BMC Bioinformatics (3 papers)Oncogene (2 papers)The Journal of Sexual Medicine (2 papers)Clinical Cancer Research (2 papers)European Urology Focus (2 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Michael Fraser
50 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 404
- Oncology 497
- Molecular Biology 1.3k
- Urology 103
- Pulmonary and Respiratory Medicine 501
Countries citing papers authored by Michael Fraser
This map shows the geographic impact of Michael Fraser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fraser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fraser more than expected).
Fields of papers citing papers by Michael Fraser
This network shows the impact of papers produced by Michael Fraser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fraser. The network helps show where Michael Fraser may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Fraser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 219 | |
| 2 | p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells. | 2003 | 168 |
| 3 | 2003 | 153 | |
| 4 | 2007 | 150 | |
| 5 | 2002 | 128 | |
| 6 | 2017 | 122 | |
| 7 | 2011 | 112 | |
| 8 | 2016 | 111 | |
| 9 | 2011 | 100 | |
| 10 | 2014 | 99 | |
| 11 | 2018 | 88 | |
| 12 | 2006 | 84 | |
| 13 | 2011 | 74 | |
| 14 | 2008 | 72 | |
| 15 | 2005 | 70 | |
| 16 | 2008 | 69 | |
| 17 | 2020 | 65 | |
| 18 | 2009 | 54 | |
| 19 | 2019 | 50 | |
| 20 | 2001 | 48 |
About Michael Fraser
Michael Fraser is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Genetics, having authored 51 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (16 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Cell death mechanisms and regulation (8 papers), Cancer-related Molecular Pathways (7 papers), Cancer Genomics and Diagnostics (6 papers), Cancer, Lipids, and Metabolism (4 papers), Molecular Biology Techniques and Applications (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Cancer Research (404 citations), Oncology (497 citations), Molecular Biology (1.3k citations), Urology (103 citations) and Pulmonary and Respiratory Medicine (501 citations). Michael Fraser has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Benjamin K. Tsang, Robert G. Bristow, Xiaojuan Yan, Theodorus van der Kwast, Xiaokui Yang, Brendan M. Leung, Tao Bai, Han C. Dan, Paul C. Boutros and Jin Q. Cheng. Their work appears in journals such as BMC Bioinformatics, Oncogene, The Journal of Sexual Medicine, Clinical Cancer Research and European Urology Focus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.